Moderna is already making preparations to launch a phase 3 study of mRNA-1018, a vaccine against H5 and H7 avian influenza viruses. The mRNA-1018 vaccine has produced “positive preliminary data ...
U.S. approves conditional use of avian influenza vaccine amid spreading outbreak U.S. greenlights temporary use of bird flu ...
This latest financial support comes on top of the $176 million BARDA gave Moderna last summer. “Avian flu variants have proven to be particularly unpredictable and dangerous to humans in the ...
Spearheaded by National Economic Council Director Kevin Hassett and USDA Secretary Brooke Rollins, the plan prioritizes ...
The U.S. Department of Agriculture on Friday granted animal vaccine company Zoetis a conditional license to use an updated ...
Health-care companies fell as a lackluster earnings season for the sector wound down. Shares of vaccine maker Moderna fell after it warned it expects to report a hefty quarterly loss, as recapturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results